CHMP recommends conditional marketing authorization for Spesolimab as first in class treatment option for generalized pustular psoriasis flares
INGELHEIM, Germany -- (BUSINESS WIRE) -- The European Medicine Agency』s Committee for Medicinal Products for Human Use (CHMP) recommended the granting of a conditional market authorization* ......
